148 related articles for article (PubMed ID: 18612507)
1. Is this pacemaker working properly? Prolongation of the atrial escape interval following activation of the ventricular safety pacing algorithm in a dual-chamber implantable cardioverter defibrillator with atrial-based, lower rate timing.
Johri AM; Baranchuk A; Simpson CS; Redfearn DP; Abdollah H
Can J Cardiol; 2008 Jul; 24(7):e43-4. PubMed ID: 18612507
[TBL] [Abstract][Full Text] [Related]
2. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
Ganjehei L; Nazeri A; Massumi A; Razavi M
Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
[TBL] [Abstract][Full Text] [Related]
3. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
[TBL] [Abstract][Full Text] [Related]
5. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
[TBL] [Abstract][Full Text] [Related]
6. Ventriculoatrial conduction metrics for classification of ventricular tachycardia with 1:1 retrograde conduction in dual-chamber sensing implantable cardioverter defibrillators.
Thompson JA; Jenkins JM
J Electrocardiol; 1998; 31 Suppl():152-6. PubMed ID: 9988021
[TBL] [Abstract][Full Text] [Related]
7. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
[TBL] [Abstract][Full Text] [Related]
8. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
[TBL] [Abstract][Full Text] [Related]
9. The role of cardioversion therapy in patients with implanted cardioverter defibrillators.
Nathan AW
Am Heart J; 1994 Apr; 127(4 Pt 2):1046-51. PubMed ID: 8160579
[TBL] [Abstract][Full Text] [Related]
10. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
[TBL] [Abstract][Full Text] [Related]
11. Treatment of drug refractory ventricular tachycardia by biventricular pacing.
Garrigue S; Barold SS; Hocini M; Jaïs P; Haïssaguerre M; Clementy J
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 1):1700-2. PubMed ID: 11138311
[TBL] [Abstract][Full Text] [Related]
12. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
Estes NA; Haugh CJ; Wang PJ; Manolis AS
Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
[TBL] [Abstract][Full Text] [Related]
13. Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
Bradfield J; Tung R; Boyle NG; Shivkumar K
Heart Fail Rev; 2011 Sep; 16(5):449-56. PubMed ID: 21451976
[TBL] [Abstract][Full Text] [Related]
14. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
15. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
16. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
17. Wide complex tachycardia and dual-chamber pacing.
Kantharia BK
Heart Rhythm; 2005 Sep; 2(9):1013-4. PubMed ID: 16171762
[No Abstract] [Full Text] [Related]
18. The points for pacing.
Warner Stevenson L
J Am Coll Cardiol; 2003 Oct; 42(8):1460-2. PubMed ID: 14563592
[No Abstract] [Full Text] [Related]
19. Dual chamber implantable cardioverter defibrillator benefits and limitations.
Fan K; Lee K; Lau CP
J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study.
Sticherling C; Zabel M; Spencker S; Meyerfeldt U; Eckardt L; Behrens S; Niehaus M;
Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):56-63. PubMed ID: 21156772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
